Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
Gold, Michael, Alderton, Claire, Zvartau-Hind, Marina, Egginton, Sally, Saunders, Ann M., Irizarry, Michael, Craft, Suzanne, Landreth, Gary, Linnamägi, Ülla, Sawchak, Sharon
Published in Dementia and geriatric cognitive disorders (01.01.2010)
Published in Dementia and geriatric cognitive disorders (01.01.2010)
Get full text
Journal Article
Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial
Tanaka, Yoshiya, Bass, Damon, Chu, Myron, Egginton, Sally, Ji, Beulah, Roth, David
Published in Modern rheumatology (03.03.2020)
Published in Modern rheumatology (03.03.2020)
Get full text
Journal Article
Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial
Tanaka, Yoshiya, Bass, Damon, Chu, Myron, Egginton, Sally, Ji, Beulah, Struemper, Herbert, Roth, David
Published in Modern rheumatology (04.05.2019)
Published in Modern rheumatology (04.05.2019)
Get full text
Journal Article
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
Zhang, Fengchun, Bae, Sang-Cheol, Bass, Damon, Chu, Myron, Egginton, Sally, Gordon, David, Roth, David A, Zheng, Jie, Tanaka, Yoshiya
Published in Annals of the rheumatic diseases (01.03.2018)
Published in Annals of the rheumatic diseases (01.03.2018)
Get full text
Journal Article